Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Revenue: 2022-2024

Historic Revenue for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Dec 2024 value amounting to $196.5 million.

  • Arcutis Biotherapeutics' Revenue rose 121.69% to $99.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $317.9 million, marking a year-over-year increase of 129.21%. This contributed to the annual value of $196.5 million for FY2024, which is 229.74% up from last year.
  • According to the latest figures from FY2024, Arcutis Biotherapeutics' Revenue is $196.5 million, which was up 229.74% from $59.6 million recorded in FY2023.
  • In the past 5 years, Arcutis Biotherapeutics' Revenue ranged from a high of $196.5 million in FY2024 and a low of $3.7 million during FY2022.
  • For the 3-year period, Arcutis Biotherapeutics' Revenue averaged around $86.6 million, with its median value being $59.6 million (2023).
  • Data for Arcutis Biotherapeutics' Revenue shows a peak YoY soared of 1,517.09% (in 2023) over the last 5 years.
  • Over the past 3 years, Arcutis Biotherapeutics' Revenue (Yearly) stood at $3.7 million in 2022, then skyrocketed by 1,517.09% to $59.6 million in 2023, then surged by 229.74% to $196.5 million in 2024.